Skip to main content Accessibility help

Downregulation of Ccnd1 and Hes6 in rat hippocampus after chronic exposure to the antidepressant paroxetine

  • Patrick C. McHugh (a1), Geraldine R. Rogers (a1), Dylan M. Glubb (a1), Melanie D. Allington (a1), Mark Hughes (a2), Peter R. Joyce (a3) and Martin A. Kennedy (a1)...



The mechanism of action of antidepressant drugs is not fully understood. Application of genomic methods enables the identification of biochemical pathways that are regulated by antidepressants, and this may provide novel clues to the molecular and cellular actions of these drugs. The present study examined gene expression profiles in the hippocampus of rats exposed to chronic antidepressant treatment.


Animals were treated for 12 days with the selective serotonin reuptake inhibitor paroxetine; then, hippocampal ribonucleic acid was recovered, and changes in gene expression were assessed by microarray analysis.


A total of 160 genes that showed differential expression after paroxetine exposure were identified. Using functional relevance and observed fold change as selection criteria, the expression changes in a subset of these genes were confirmed by quantitative polymerase chain reaction.


Of this subset, only two genes, cyclin D1 (Ccnd1) and hairy and enhancer of split 6 (Hes6), showed robust and consistent changes in expression. Both genes were downregulated by paroxetine, and both have been previously implicated in neurogenesis. Further investigation of these two genes may provide new insight into the mechanism of action of antidepressants.


Corresponding author

Associate Professor Martin A. Kennedy, Department of Pathology, University of Otago, Christchurch, PO Box 4345, Christchurch 8011, New Zealand. Tel: (64-3) 364-1222; Fax: (64-3) 364-0009; E-mail:


Hide All
1.Elhwuegi, AS. Central monoamines and their role in major depression. Prog Neuropsychopharmacol Biol Psychiatry 2004;28:435451.
2.Ressler, KJ, Nemeroff, CB. Role of norepinephrine in the pathophysiology and treatment of mood disorders. Biol Psychiatry 1999;46:12191233.
3.Nestler, EJ. Antidepressant treatments in the 21st century. Biol Psychiatry 1998;44:526533.
4.Dubovsky, SL. Beyond the serotonin reuptake inhibitors: rationales for the development of new serotonergic agents. J Clin Psychiatry 1994;55(Suppl.):3444.
5.Malberg, JE, Blendy, JA. Antidepressant action: to the nucleus and beyond. Trends Pharmacol Sci 2005;26:631638.
6.Malberg, JE, Duman, RS. Cell proliferation in adult hippocampus is decreased by inescapable stress: reversal by fluoxetine treatment. Neuropsychopharmacology 2003;28:15621571.
7.McEwen, BS. Stress and hippocampal plasticity. Annu Rev Neurosci 1999;22:105122.
8.Schiepers, OJ, Wichers, MC, Maes, M. Cytokines and major depression. Prog Neuropsychopharmacol Biol Psychiatry 2005;29:201217.
9.Zorrilla, EP, Valdez, GR, Weiss, F. Changes in levels of regional CRF-like-immunoreactivity and plasma corticosterone during protracted drug withdrawal in dependent rats. Psychopharmacology (Berl) 2001;158:374381.
10.Czeh, B, Lucassen, PJ. What causes the hippocampal volume decrease in depression?: Are neurogenesis, glial changes and apoptosis implicated? Eur Arch Psychiatry Clin Neurosci 2007;257:250260.
11.Young, EA, Haskett, RF, Murphy-Weinberg, V, Watson, SJ, Akil, H. Loss of glucocorticoid fast feedback in depression. Arch Gen Psychiatry 1991;48:693699.
12.Kaestner, F, Hettich, M, Peters, Met al. Different activation patterns of proinflammatory cytokines in melancholic and non-melancholic major depression are associated with HPA axis activity. J Affect Disord 2005;87:305311.
13.Gur, TL, Conti, AC, Holden, Jet al. cAMP response element-binding protein deficiency allows for increased neurogenesis and a rapid onset of antidepressant response. J Neurosci 2007;27:78607868.
14.Santarelli, L, Saxe, M, Gross, Cet al. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 2003;301:805809.
15.Brazma, A, Hingamp, P, Quackenbush, Jet al. Minimum information about a microarray experiment (MIAME) – toward standards for microarray data. Nat Genet 2001;29:365371.
16.DeVane, CL. Metabolism and pharmacokinetics of selective serotonin reuptake inhibitors. Cell Mol Neurobiol 1999;19:443466.
17.Yang, IV, Chen, E, Hasseman, JPet al. Within the fold: assessing differential expression measures and reproducibility in microarray assays. Genome Biol 2002;3:research0062.
18.Rajeevan, MS, Vernon, SD, Taysavang, N, Unger, ER. Validation of array-based gene expression profiles by real-time (kinetic) RT-PCR. J Mol Diagn 2001;3:2631.
19.Wang, Y, Barbacioru, C, Hyland, Fet al. Large scale real-time PCR validation on gene expression measurements from two commercial long-oligonucleotide microarrays. BMC Genomics 2006;7:59.
20.Jurata, LW, Bukhman, YV, Charles, Vet al. Comparison of microarray-based mRNA profiling technologies for identification of psychiatric disease and drug signatures. J Neurosci Methods 2004;138:173188.
21.Wurmbach, E, Gonzalez-Maeso, J, Yuen, Tet al. Validated genomic approach to study differentially expressed genes in complex tissues. Neurochem Res 2002;27:10271033.
22.Sherr, CJ, Roberts, JM. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 1999;13:15011512.
23.Fu, M, Wang, C, Li, Z, Sakamaki, T, Pestell, RG. Minireview: cyclin D1: normal and abnormal functions. Endocrinology 2004;145:54395447.
24.Bienvenu, F, Gascan, H, Coqueret, O. Cyclin D1 represses STAT3 activation through a Cdk4-independent mechanism. J Biol Chem 2001;276:1684016847.
25.Gertsch, J, Guttinger, M, Sticher, O, Heilmann, J. Relative quantification of mRNA levels in Jurkat T cells with RT-real time-PCR (RT-rt-PCR): new possibilities for the screening of anti-inflammatory and cytotoxic compounds. Pharm Res 2002;19:12361243.
26.Landgrebe, J, Welzl, G, Metz, Tet al. Molecular characterisation of antidepressant effects in the mouse brain using gene expression profiling. J Psychiatr Res 2002;36:119129.
27.Drigues, N, Poltyrev, T, Bejar, C, Weinstock, M, Youdim, MB. cDNA gene expression profile of rat hippocampus after chronic treatment with antidepressant drugs. J Neural Transm 2003;110:14131436.
28.Chen, J, Zhang, Y, Kelz, MBet al. Induction of cyclin-dependent kinase 5 in the hippocampus by chronic electroconvulsive seizures: role of [Delta]FosB. J Neurosci 2000;20:89658971.
29.Newton, SS, Collier, EF, Hunsberger, Jet al. Gene profile of electroconvulsive seizures: induction of neurotrophic and angiogenic factors. J Neurosci 2003;23:1084110851.
30.Koyano-Nakagawa, N, Kim, J, Anderson, D, Kintner, C. Hes6 acts in a positive feedback loop with the neurogenins to promote neuronal differentiation. Development 2000;127:42034216.
31.Bae, S, Bessho, Y, Hojo, M, Kageyama, R. The bHLH gene Hes6, an inhibitor of Hes1, promotes neuronal differentiation. Development 2000;127:29332943.
32.Kageyama, R, Ishibashi, M, Takebayashi, K, Tomita, K. bHLH transcription factors and mammalian neuronal differentiation. Int J Biochem Cell Biol 1997;29:13891399.
33.Altar, CA, Laeng, P, Jurata, LWet al. Electroconvulsive seizures regulate gene expression of distinct neurotrophic signaling pathways. J Neurosci 2004;24:26672677.
34.Kamakura, S, Oishi, K, Yoshimatsu, T, Nakafuku, M, Masuyama, N, Gotoh, Y. Hes binding to STAT3 mediates crosstalk between Notch and JAK-STAT signalling. Nat Cell Biol 2004;6:547554.
35.Wong, ML, O’Kirwan, F, Hannestad, JP, Irizarry, KJ, Elashoff, D, Licinio, J. St John’s wort and imipramine-induced gene expression profiles identify cellular functions relevant to antidepressant action and novel pharmacogenetic candidates for the phenotype of antidepressant treatment response. Mol Psychiatry 2004;9:237251.
36.Conti, B, Maier, R, Barr, AMet al. Region-specific transcriptional changes following the three antidepressant treatments electro convulsive therapy, sleep deprivation and fluoxetine. Mol Psychiatry 2006;12:167189.
37.Fior, R, Henrique, D. A novel hes5/hes6 circuitry of negative regulation controls Notch activity during neurogenesis. Dev Biol 2005;281:318333.
38.Chen, B, Wang, JF, Sun, X, Young, LT. Regulation of GAP-43 expression by chronic desipramine treatment in rat cultured hippocampal cells. Biol Psychiatry 2003;53:530537.
39.Palotas, M, Palotas, A, Puskas, LGet al. Gene expression profile analysis of the rat cortex following treatment with imipramine and citalopram. Int J Neuropsychopharmacol 2004;7:401413.
40.Yamada, M, Takahashi, K, Tsunoda, Met al. Differential expression of VAMP2/synaptobrevin-2 after antidepressant and electroconvulsive treatment in rat frontal cortex. Pharmacogenomics J 2002;2:377382.
41.Yamada, M, Yamazaki, S, Takahashi, Ket al. Induction of cysteine string protein after chronic antidepressant treatment in rat frontal cortex. Neurosci Lett 2001;301:183186.
42.Yamada, M, Yamazaki, S, Takahashi, Ket al. Identification of a novel gene with RING-H2 finger motif induced after chronic antidepressant treatment in rat brain. Biochem Biophys Res Commun 2000;278:150157.
43.Huang, NY, Strakhova, M, Layer, RT, Skolnick, P. Chronic antidepressant treatments increase cytochrome b mRNA levels in mouse cerebral cortex. J Mol Neurosci 1997;9:167176.
44.Wong, ML, Khatri, P, Licinio, J, Esposito, A, Gold, PW. Identification of hypothalamic transcripts upregulated by antidepressants. Biochem Biophys Res Commun 1996;229:275279.
45.Yamada, M, Kiuchi, Y, Nara, Ket al. Identification of a novel splice variant of heat shock cognate protein 70 after chronic antidepressant treatment in rat frontal cortex. Biochem Biophys Res Commun 1999;261:541545.
46.Chen, J, Newton, SS, Zeng, Let al. Downregulation of the CCAAT-enhancer binding protein beta in deltaFosB transgenic mice and by electroconvulsive seizures. Neuropsychopharmacology 2004;29:2331.
47.Rausch, JL, Gillespie, CF, Fei, Yet al. Antidepressant effects on kinase gene expression patterns in rat brain. Neurosci Lett 2002;334:9194.
48.Kothapalli, R, Yoder, SJ, Mane, S, Loughran, TP Jr. Microarray results: how accurate are they? BMC Bioinformatics 2002;3:22.
49.Chuaqui, RF, Bonner, RF, Best, CJet al. Post-analysis follow-up and validation of microarray experiments. Nat Genet 2002;32(Suppl.):509514.
50.Duman, CH, Schlesinger, L, Kodama, M, Russell, DS, Duman, RS. A role for MAP kinase signaling in behavioral models of depression and antidepressant treatment. Biol Psychiatry 2007;61:661670.
51.Nakagawa, S, Kim, JE, Lee, Ret al. Regulation of neurogenesis in adult mouse hippocampus by cAMP and the cAMP response element-binding protein. J Neurosci 2002;22:36733682.
52.Fujioka, T, Fujioka, A, Duman, RS. Activation of cAMP signaling facilitates the morphological maturation of newborn neurons in adult hippocampus. J Neurosci 2004;24:319328.
53.Celano, E, Tiraboschi, E, Consogno, Eet al. Selective regulation of presynaptic calcium/calmodulin-dependent protein kinase II by psychotropic drugs. Biol Psychiatry 2003;53:442449.
54.McHugh, PC, Rogers, GR, Loudon, B, Glubb, DM, Joyce, PR, Kennedy, MA. Proteomic analysis of embryonic stem cell-derived neural cells exposed to the antidepressant paroxetine. J Neurosci Res 2008;86:306316.
55.Guo, GG, Patel, K, Kumar, Vet al. Association of the chaperone glucose-regulated protein 58 (GRP58/ER-60/ERp57) with Stat3 in cytosol and plasma membrane complexes. J Interferon Cytokine Res 2002;22:555563.
56.Sehgal, PB. Plasma membrane rafts and chaperones in cytokine/STAT signaling. Acta Biochim Pol 2003;50:583594.
57.Fricker, AD, Rios, C, Devi, LA, Gomes, I. Serotonin receptor activation leads to neurite outgrowth and neuronal survival. Brain Res Mol Brain Res 2005;138:228235.
58.Lein, ES, Hawrylycz, MJ, Ao, Net al. Genome-wide atlas of gene expression in the adult mouse brain. Nature 2007;445:168176.
59.Paizanis, E, Hamon, M, Lanfumey, L. Hippocampal neurogenesis, depressive disorders, and antidepressant therapy. Neural Plast 2007;2007:73754.
60.Marcussen, AB, Flagstad, P, Kristjansen, PE, Johansen, FF, Englund, U. Increase in neurogenesis and behavioural benefit after chronic fluoxetine treatment in Wistar rats. Acta Neurol Scand 2008;117:94100.
61.Qiu, G, Helmeste, DM, Samaranayake, ANet al. Modulation of the suppressive effect of corticosterone on adult rat hippocampal cell proliferation by paroxetine. Neurosci Bull 2007;23:131136.
62.Thakker-Varia, S, Krol, JJ, Nettleton, Jet al. The neuropeptide VGF produces antidepressant-like behavioral effects and enhances proliferation in the hippocampus. J Neurosci 2007;27:1215612167.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Acta Neuropsychiatrica
  • ISSN: 0924-2708
  • EISSN: 1601-5215
  • URL: /core/journals/acta-neuropsychiatrica
Please enter your name
Please enter a valid email address
Who would you like to send this to? *



Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed